Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ABO Blood-Group System | 5 | 2018 | 17 | 1.560 |
Why?
|
| HLA Antigens | 4 | 2014 | 40 | 1.020 |
Why?
|
| Blood Group Incompatibility | 3 | 2016 | 8 | 0.940 |
Why?
|
| Blood Preservation | 2 | 2020 | 8 | 0.680 |
Why?
|
| Kidney Transplantation | 2 | 2016 | 490 | 0.670 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2020 | 8 | 0.650 |
Why?
|
| Erythrocytes | 2 | 2018 | 41 | 0.590 |
Why?
|
| Erythrocyte Transfusion | 3 | 2020 | 27 | 0.540 |
Why?
|
| Medical Waste | 1 | 2017 | 1 | 0.530 |
Why?
|
| Cold Temperature | 1 | 2017 | 56 | 0.520 |
Why?
|
| Platelet Transfusion | 3 | 2020 | 15 | 0.500 |
Why?
|
| Blood Transfusion | 2 | 2023 | 69 | 0.480 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2015 | 3 | 0.440 |
Why?
|
| Herpesvirus 4, Human | 1 | 2015 | 8 | 0.440 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2015 | 10 | 0.440 |
Why?
|
| Blood Donors | 4 | 2018 | 11 | 0.430 |
Why?
|
| Autoantibodies | 1 | 2015 | 50 | 0.430 |
Why?
|
| Blood Platelets | 2 | 2020 | 59 | 0.420 |
Why?
|
| Blood Component Transfusion | 2 | 2019 | 10 | 0.410 |
Why?
|
| Antibodies | 3 | 2016 | 56 | 0.370 |
Why?
|
| Adult | 9 | 2020 | 9259 | 0.330 |
Why?
|
| Humans | 18 | 2023 | 32284 | 0.320 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 534 | 0.310 |
Why?
|
| Hemorrhage | 1 | 2019 | 95 | 0.280 |
Why?
|
| Immunoassay | 1 | 2008 | 16 | 0.280 |
Why?
|
| Isoantibodies | 1 | 2008 | 11 | 0.270 |
Why?
|
| Hypersensitivity | 1 | 2008 | 24 | 0.270 |
Why?
|
| Plasma | 1 | 2017 | 14 | 0.260 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2007 | 2 | 0.260 |
Why?
|
| Leukopenia | 1 | 2007 | 9 | 0.260 |
Why?
|
| Male | 11 | 2020 | 19443 | 0.250 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2007 | 50 | 0.250 |
Why?
|
| Neutrophils | 1 | 2007 | 120 | 0.240 |
Why?
|
| Pigmentation | 1 | 2006 | 6 | 0.240 |
Why?
|
| Thyroid Gland | 1 | 2006 | 16 | 0.240 |
Why?
|
| Thyroid Neoplasms | 1 | 2006 | 34 | 0.230 |
Why?
|
| Female | 11 | 2020 | 19947 | 0.220 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 242 | 0.220 |
Why?
|
| Blood Banks | 2 | 2018 | 6 | 0.200 |
Why?
|
| Hospitals | 2 | 2019 | 95 | 0.190 |
Why?
|
| Critical Care | 1 | 2023 | 108 | 0.180 |
Why?
|
| Hemolysis | 2 | 2016 | 11 | 0.180 |
Why?
|
| Middle Aged | 8 | 2018 | 11853 | 0.180 |
Why?
|
| Histocompatibility Testing | 2 | 2014 | 25 | 0.170 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 19 | 0.160 |
Why?
|
| Plateletpheresis | 1 | 2020 | 3 | 0.160 |
Why?
|
| Sepsis | 1 | 2020 | 164 | 0.140 |
Why?
|
| Risk Factors | 2 | 2023 | 3934 | 0.140 |
Why?
|
| Trauma Centers | 2 | 2019 | 84 | 0.130 |
Why?
|
| Aged | 4 | 2018 | 10265 | 0.120 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2016 | 6 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2020 | 3628 | 0.120 |
Why?
|
| Complement Activation | 1 | 2016 | 8 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2016 | 186 | 0.110 |
Why?
|
| Cryoglobulins | 1 | 2015 | 4 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2015 | 55 | 0.110 |
Why?
|
| Brain Death | 1 | 2014 | 23 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 129 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2014 | 236 | 0.100 |
Why?
|
| Adolescent | 3 | 2017 | 3519 | 0.090 |
Why?
|
| Rh-Hr Blood-Group System | 2 | 2018 | 5 | 0.080 |
Why?
|
| Young Adult | 2 | 2018 | 2649 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3902 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2019 | 65 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 28 | 0.070 |
Why?
|
| Maryland | 1 | 2008 | 27 | 0.070 |
Why?
|
| Microspheres | 1 | 2008 | 45 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2007 | 50 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2007 | 46 | 0.060 |
Why?
|
| Resuscitation | 1 | 2017 | 66 | 0.060 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2006 | 2 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3416 | 0.060 |
Why?
|
| Antilymphocyte Serum | 1 | 2006 | 40 | 0.060 |
Why?
|
| Color | 1 | 2006 | 12 | 0.060 |
Why?
|
| Sex Factors | 1 | 2018 | 657 | 0.060 |
Why?
|
| Cytodiagnosis | 1 | 2006 | 15 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2017 | 197 | 0.060 |
Why?
|
| Length of Stay | 1 | 2017 | 321 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2008 | 854 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2006 | 62 | 0.060 |
Why?
|
| Prevalence | 1 | 2008 | 955 | 0.060 |
Why?
|
| Age Factors | 1 | 2018 | 1179 | 0.050 |
Why?
|
| Child | 1 | 2017 | 2435 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 42 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1479 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 2205 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 1425 | 0.020 |
Why?
|
| Bone Marrow Diseases | 1 | 2006 | 2 | 0.020 |
Why?
|
| Anemia, Aplastic | 1 | 2006 | 4 | 0.020 |
Why?
|
| Clone Cells | 1 | 2006 | 35 | 0.020 |
Why?
|
| Models, Biological | 1 | 2007 | 408 | 0.010 |
Why?
|